GLP-1s Now ‘Predominant Driver’ of Drug Spend Growth

The weight loss drugs are behind a historic increase in traditional drug spending as employers seek to meet high employee demand.
Share This Post
Related Articles
Receive the latest updates

Subscribe To
Our Quarterly Newsletter

Get notified about new blog posts, case studies, white papers, and more!